BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 18678578)

  • 1. Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study.
    Mease PJ; Hobbs K; Chalmers A; El-Gabalawy H; Bookman A; Keystone E; Furst DE; Anklesaria P; Heald AE
    Ann Rheum Dis; 2009 Aug; 68(8):1247-54. PubMed ID: 18678578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study.
    Mease PJ; Wei N; Fudman EJ; Kivitz AJ; Schechtman J; Trapp RG; Hobbs KF; Greenwald M; Hou A; Bookbinder SA; Graham GE; Wiesenhutter CW; Willis L; Ruderman EM; Forstot JZ; Maricic MJ; Dao KH; Pritchard CH; Fiske DN; Burch FX; Prupas HM; Anklesaria P; Heald AE
    J Rheumatol; 2010 Apr; 37(4):692-703. PubMed ID: 20032102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.
    Moreland LW; Baumgartner SW; Schiff MH; Tindall EA; Fleischmann RM; Weaver AL; Ettlinger RE; Cohen S; Koopman WJ; Mohler K; Widmer MB; Blosch CM
    N Engl J Med; 1997 Jul; 337(3):141-7. PubMed ID: 9219699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis.
    Bliddal H; Terslev L; Qvistgaard E; Konig M; Holm CC; Rogind H; Boesen M; Danneskiold-Samsøe B; Torp-Pedersen S
    Scand J Rheumatol; 2006; 35(5):341-5. PubMed ID: 17062431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritis.
    Rau R; Sander O; van Riel P; van de Putte L; Hasler F; Zaug M; Kneer J; van der Auwera P; Stevens RM;
    J Rheumatol; 2003 Apr; 30(4):680-90. PubMed ID: 12672184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-articular delivery of a herpes simplex virus IL-1Ra gene vector reduces inflammation in a rabbit model of arthritis.
    Oligino T; Ghivizzani S; Wolfe D; Lechman E; Krisky D; Mi Z; Evans C; Robbins P; Glorioso J
    Gene Ther; 1999 Oct; 6(10):1713-20. PubMed ID: 10516720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein, Ro 45-2081 (lenercept): results of a dose-finding study in rheumatoid arthritis.
    Furst DE; Weisman M; Paulus HE; Bulpitt K; Weinblatt M; Polisson R; Zaug M; Kneer J; Van der Auwera P; Stevens RM
    J Rheumatol; 2003 Oct; 30(10):2123-6. PubMed ID: 14528504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritis.
    Moreland LW; Margolies G; Heck LW; Saway A; Blosch C; Hanna R; Koopman WJ
    J Rheumatol; 1996 Nov; 23(11):1849-55. PubMed ID: 8923355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation-inducible anti-TNF gene expression mediated by intra-articular injection of serotype 5 adeno-associated virus reduces arthritis.
    Khoury M; Adriaansen J; Vervoordeldonk MJ; Gould D; Chernajovsky Y; Bigey P; Bloquel C; Scherman D; Tak PP; Jorgensen C; Apparailly F
    J Gene Med; 2007 Jul; 9(7):596-604. PubMed ID: 17514770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical safety evaluation of recombinant adeno-associated virus 2 vector encoding human tumor necrosis factor receptor-immunoglobulin Fc fusion gene.
    Zhou X; Shen L; Liu L; Wang C; Qi W; Zhao A; Wu X; Li B
    Hum Vaccin Immunother; 2016 Mar; 12(3):732-9. PubMed ID: 26837862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computed tomography guided intra-articular injection of etanercept in the sacroiliac joint is an effective mode of treatment of ankylosing spondylitis.
    Cui Y; Xiao Z; Shuxia W; Zhenjun Z; Hengguo Z; Liangyi F; Weicheng G; Li L; Guangfeng Z; Yunzhen S; Guangfu D
    Scand J Rheumatol; 2010 May; 39(3):229-32. PubMed ID: 20109079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group.
    Fisher CJ; Agosti JM; Opal SM; Lowry SF; Balk RA; Sadoff JC; Abraham E; Schein RM; Benjamin E
    N Engl J Med; 1996 Jun; 334(26):1697-702. PubMed ID: 8637514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraarticular gene transfer of TNFR:Fc suppresses experimental arthritis with reduced systemic distribution of the gene product.
    Chan JM; Villarreal G; Jin WW; Stepan T; Burstein H; Wahl SM
    Mol Ther; 2002 Dec; 6(6):727-36. PubMed ID: 12498769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electro-gene therapy of collagen-induced arthritis by using an expression plasmid for the soluble p75 tumor necrosis factor receptor-Fc fusion protein.
    Kim JM; Ho SH; Hahn W; Jeong JG; Park EJ; Lee HJ; Yu SS; Lee CS; Lee YW; Kim S
    Gene Ther; 2003 Aug; 10(15):1216-24. PubMed ID: 12858186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agent.
    Adriaansen J; Khoury M; de Cortie CJ; Fallaux FJ; Bigey P; Scherman D; Gould DJ; Chernajovsky Y; Apparailly F; Jorgensen C; Vervoordeldonk MJ; Tak PP
    Ann Rheum Dis; 2007 Sep; 66(9):1143-50. PubMed ID: 17363402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adeno-associated virus type 5-mediated intraarticular administration of tumor necrosis factor small interfering RNA improves collagen-induced arthritis.
    Khoury M; Courties G; Fabre S; Bouffi C; Seemayer CA; Vervoordeldonk MJ; Tak PP; Jorgensen C; Apparailly F
    Arthritis Rheum; 2010 Mar; 62(3):765-70. PubMed ID: 20187132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy.
    Adriaansen J; Tas SW; Klarenbeek PL; Bakker AC; Apparailly F; Firestein GS; Jorgensen C; Vervoordeldonk MJ; Tak PP
    Ann Rheum Dis; 2005 Dec; 64(12):1677-84. PubMed ID: 15878906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocarditis following adeno-associated viral gene expression of human soluble TNF receptor (TNFRII-Fc) in baboon hearts.
    McTiernan CF; Mathier MA; Zhu X; Xiao X; Klein E; Swan CH; Mehdi H; Gibson G; Trichel AM; Glorioso JC; Feldman AM; McCurry KR; London B
    Gene Ther; 2007 Dec; 14(23):1613-22. PubMed ID: 17851548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation and radiological observation of recombinant human tumor necrosis factor receptor-Fc fusion protein in treatment of active ankylosing spondylitis].
    Pan XY; Li J; Pang J; Dai SH; Chen WG
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1408-11. PubMed ID: 18953881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gene therapy for osteoarticular disorders].
    Gouze JN; Evans CH; Ghivizzani SC; Gouze E
    Med Sci (Paris); 2007 Mar; 23(3):303-9. PubMed ID: 17349293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.